Celldex Therapeutics | CLDX - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Celldex Therapeutics USD 724.93M 265.71M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Northwest Biotherapeutics USD 6.2M 996K 2026-03
Pfizer USD 41.36B 1.46B 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06